For older adults with incidentally detected splenomegaly, a very large spleen volume predicts a substantial risk for ...

Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions. Ojjaara (momelotinib) is the first treatment of ...

Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07 We retrospectively assessed the relationship between chemotherapy ...

SAN DIEGO ― Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a major indicator of clinical improvement – compared with ...

Please provide your email address to receive an email when new articles are posted on . Pelabresib plus ruxolitinib conferred benefit to Janus kinase inhibitor-naive patients with myelofibrosis, ...

Spleen is the biggest lymphatic organ in the body and its major roles are to create blood (hematopoiesis), to store blood, to filter the blood and to generate immunological responses. The spleen’s ...